Chemomab Therapeutics (CMMB) Net Cash Flow (2017 - 2023)
Chemomab Therapeutics (CMMB) posted Net Cash Flow of $140000.0 for Q4 2023, up 111.4% on a QoQ basis from -$1.2 million in Q3 2023, and down 94.96% year-over-year from $2.8 million in Q4 2022.
Chemomab Therapeutics (CMMB) Net Cash Flow (2017 - 2023) Analysis & Trends
Chemomab Therapeutics' Net Cash Flow history runs 7 years deep, the most recent figure standing at $140000.0 for Q4 2023.
- Quarterly Net Cash Flow fell 94.96% year-over-year to $140000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $140000.0 (up 108.81% YoY) and the FY2025 annual result came in at $1.4 million, up 143.99% from the prior year.
- Net Cash Flow was $140000.0 for Q4 2023 at Chemomab Therapeutics, up from -$1.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $46.5 million in Q1 2021 and bottomed at -$22.6 million in Q4 2021.
- A 5-year average of $357750.0 and a median of -$1.3 million in 2022 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 3368.03% in 2021, while the deepest fall reached 2166.93% in 2021.
- Chemomab Therapeutics' Net Cash Flow stood at -$5.7 million in 2019, then soared by 82.43% to -$995000.0 in 2020, then slumped by 2166.93% to -$22.6 million in 2021, then soared by 112.32% to $2.8 million in 2022, then plunged by 94.96% to $140000.0 in 2023.
- Business Quant data shows CMMB's Net Cash Flow at $140000.0 in Q4 2023, -$1.2 million in Q3 2023, and -$10.4 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 140,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Sep 30, 2023 | -1.23 Mn |
| Sep 30, 2023 | -1.23 Mn |
| Jun 30, 2023 | -10.39 Mn |
| Jun 30, 2023 | -10.39 Mn |
| Mar 31, 2023 | 7.25 Mn |
| Mar 31, 2023 | 7.25 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 858,000.00 |
| Sep 30, 2022 | 858,000.00 |
| Jun 30, 2022 | -3.95 Mn |
| Jun 30, 2022 | -3.95 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Dec 31, 2021 | -22.56 Mn |
| Dec 31, 2021 | -22.56 Mn |
| Sep 30, 2021 | -7.65 Mn |
| Sep 30, 2021 | -7.65 Mn |